Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma

被引:0
|
作者
Mantovani, G. [1 ]
机构
[1] Univ Cagliari, Dept Med Oncol, I-09124 Cagliari, Italy
关键词
D O I
10.1093/annonc/mdn290
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1355 / 1355
页数:1
相关论文
共 50 条
  • [1] Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma
    Porta, C.
    De Amici, M.
    Quaglini, S.
    Paglino, C.
    Tagliani, F.
    Boncimino, A.
    Moratti, R.
    Corazza, G. R.
    ANNALS OF ONCOLOGY, 2008, 19 (02) : 353 - 358
  • [2] Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy
    Myojin, Yuta
    Kodama, Takahiro
    Sakamori, Ryotaro
    Maesaka, Kazuki
    Matsumae, Takayuki
    Sawai, Yoshiyuki
    Imai, Yasuharu
    Ohkawa, Kazuyoshi
    Miyazaki, Masanori
    Tanaka, Satoshi
    Mita, Eiji
    Tawara, Seiichi
    Yakushijin, Takayuki
    Nozaki, Yasutoshi
    Hagiwara, Hideki
    Tahata, Yuki
    Yamada, Ryoko
    Hikita, Hayato
    Tatsumi, Tomohide
    Takehara, Tetsuo
    CANCERS, 2022, 14 (04)
  • [3] CIRCULATING INTERLEUKIN-6 AS A USEFUL MARKER FOR PREDICTING POSTOPERATIVE COMPLICATIONS
    OKA, Y
    MURATA, A
    NISHIJIMA, J
    YASUDA, T
    HIRAOKA, N
    OHMACHI, Y
    KITAGAWA, K
    YASUDA, T
    TODA, H
    TANAKA, N
    MORI, T
    CYTOKINE, 1992, 4 (04) : 298 - 304
  • [4] Association of interleukin-6 polymorphisms with susceptibility to hepatocellular carcinoma
    Zheng, Xiaohuan
    Han, Cuiping
    Shan, Rong
    Zhang, Haitao
    Zheng, Zhaomin
    Liu, Yuanshui
    Wang, Aiguang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (04): : 6252 - 6256
  • [5] Interleukin-6 in Hepatocellular Carcinoma: A Dualistic Point of View
    Nenu, Iuliana
    Toadere, Teodora Maria
    Topor, Ioan
    Tichindeleanu, Andra
    Bondor, Daniela Andreea
    Trella, Serban Ellias
    Sparchez, Zeno
    Filip, Gabriela Adriana
    BIOMEDICINES, 2023, 11 (10)
  • [6] Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma
    Hsia, C. -Y.
    Huo, T-I.
    Chiang, S. -Y.
    Lu, M. -F.
    Sun, C. -L.
    Wu, J. -C.
    Lee, P. -C.
    Chi, C. -W.
    Lui, W. -Y.
    Lee, S. -D.
    EJSO, 2007, 33 (02): : 208 - 212
  • [7] Evaluation of interleukin-6, interleukin-10, and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma
    Hsia, Cheng-Yuan
    Huo, Teh-Ia
    Chiang, Shu-Yuan
    Lu, Ming-Fong
    Wu, Jaw-Ching
    Lui, Wing-Yiu
    Lee, Shou-Dong
    Wu, Chew-Wun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A187 - A187
  • [8] Interleukin-6 induced by YAP in hepatocellular carcinoma cells recruits tumor-associated macrophages
    Zhou, Tian-yi
    Zhou, Yu-lu
    Qian, Mei-jia
    Fang, Yi-zheng
    Ye, Song
    Xin, Wen-xiu
    Yang, Xiao-chun
    Wu, Hong-hai
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2018, 138 (02) : 89 - 95
  • [9] Preoperative Levels of Serum Interleukin-6 in Patients with Hepatocellular Carcinoma
    Pang, Xiong-Hao
    Zhang, Jing-Ping
    Zhang, Yao-Jun
    Yan, Jing
    Pei, Xiao-Qing
    Zhang, Ya-Qi
    Li, Jin-Qing
    Zheng, Limin
    Chen, Min-Shan
    HEPATO-GASTROENTEROLOGY, 2011, 58 (110) : 1687 - 1693
  • [10] Microencapsulation of engineered cells to deliver sustained high circulating levels of interleukin-6 to study hepatocellular carcinoma progression
    Moran, Diarmuid M.
    Koniaris, Leonidas G.
    Jablonski, Elizabeth M.
    Cahill, Paul A.
    Halberstadt, Craig R.
    McKillop, Iain H.
    CELL TRANSPLANTATION, 2006, 15 (8-9) : 785 - 798